14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 4 days ( -12.11 % )
Last Price $2.13 13.30 %
High/ Low $1.87 - $2.19 46.79%
Chg 7 Days 56.04 % $1.37 $2.13
Chg 30 Days 20.34 % $1.77 $2.13
Chg 12 mos -53.80 % $4.61 $2.13
Trend - 3 mos -26.55 % Width: 63.48 %
Trend - 12 mos -47.49 % Width: 106.25 %
Pred. range - 3 mos $0.96 - $1.56 -55.07 % - -26.55 %
Pred. range - 12 mos $0.691 - $1.43 -67.55 % - -33.08 %
Short MA avg 3 mos Buy Apr 29, 2024 - 5 days
Long MA avg 3 mos Buy Apr 29, 2024 - 5 days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Apr 29, 2024 - 5 days
Long MA avg 12 mos Buy Feb 09, 2024 - 59 days
Short/Long MA avg 12 mos Sell Feb 20, 2024 - 53 days
Pivot Short Buy Apr 26, 2024 - 6 days
Bollinger Buy Apr 15, 2024 - 15 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Cue Biopharma Inc.

Cue Biopharma. Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-10... CUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT